The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors.

Butler, Javed; Hamo, Carine E; Filippatos, Gerasimos; Pocock, Stuart J; Bernstein, Richard A; Brueckmann, Martina; Cheung, Alfred K; George, Jyothis T; Green, Jennifer B; Januzzi, James L; +19 more... Kaul, Sanjay; Lam, Carolyn SP; Lip, Gregory YH; Marx, Nikolaus; McCullough, Peter A; Mehta, Cyrus R; Ponikowski, Piotr; Rosenstock, Julio; Sattar, Naveed; Salsali, Afshin; Scirica, Benjamin M; Shah, Sanjiv J; Tsutsui, Hiroyuki; Verma, Subodh; Wanner, Christoph; Woerle, Hans-Juergan; Zannad, Faiez; Anker, Stefan D; EMPEROR Trials Program; (2017) The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors. European journal of heart failure, 19 (11). pp. 1390-1400. ISSN 1388-9842 DOI: https://doi.org/10.1002/ejhf.933

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1002/ejhf.933

Abstract

Share

Download

Filename: The-Potential-Role-and-Rationale-for-Treatment-of-Heart-Failure-with-SGLT2-Inhibitors.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar